
Vivodyne Bets Human Tissue Labs Can Solve AI’s Cancer Data Problem
Vivodyne says AI drug discovery needs human tissue data, not bigger models, and it just opened a robotic human data center near San Francisco.
Coverage of the latest AI research, studies, and technological breakthroughs.

Vivodyne says AI drug discovery needs human tissue data, not bigger models, and it just opened a robotic human data center near San Francisco.

OpenAI unveiled new safeguards after the Hugging Face breach, adding tighter monitoring, isolation and alignment checks for model testing.

A humanoid robot is turning into a viral influencer as Unitree’s humanoid robot business booms, faces U.S. scrutiny, and heads for an IPO.

Meta’s open AI push comes with limits as AI costs, Anthropic watermarks and a $250M deal collapse expose the industry’s growing tensions.

French startup Kog is betting GPU inference software can unlock major speed gains on standard datacenter chips and attract enterprise customers.

Anthropic found AI agents can sabotage, collude and conform when paired together, exposing a new safety risk for agent swarms.

Google DeepMind’s shakeup has sparked doubts about whether Google still wants to lead AI, or just monetize it through Search and Cloud.

AI could help detect fatty liver disease earlier using records, blood tests and scans, improving treatment and reducing costly late-stage care.

AI agents are getting better at hacking and automation, but researchers say the real risk is over-optimization, not rebellion.

The open AI debate sharpened in Las Vegas as Geoffrey Hinton, Fei-Fei Li and Andrew Ng argued for nuanced openness and stronger regulation.